Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation

This publication has 28 references indexed in Scilit:

• Antisense oligonucleotides for cancer therapy—an overview
  Lung Cancer, 2003
• Translation repression by antisense sequences
  Cellular and Molecular Life Sciences, 2003
• DNA Nanoparticles and Development of DNA Delivery Vehicles for Gene Therapy
  Biochemistry, 2002
• Nanoparticulate systems for brain delivery of drugs
  Published by Elsevier ,2001
• Inhibition of Translation of Hepatitis C Virus RNA by 2′-Modified Antisense Oligonucleotides
  Antisense and Nucleic Acid Drug Development, 1999
• Regulation of the angiotensin type-1 receptor by antisense oligonucleotides occurs through an RNase H-type mechanism
  Molecular Brain Research, 1999
• The Multiple Inhibitory Mechanisms of GEM 91®, agagAntisense Phosphorothioate Oligonucleotide, for Human Immunodeficiency Virus Type 1
  AIDS Research and Human Retroviruses, 1997
• Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5′-LTR region of the viral genome
  Gene, 1995
• Gene-targeted inhibition of transactivation of human immunodeficiency virus type-1 (HIV-1)-LTR by antisense oligonucleotides
  Virus Genes, 1995
• Target-specific arrest of mRNA tranlation by antisense 2′-O-alkyloligoribonucleotides
  Nucleic Acids Research, 1994